Discover Cell, the premier biotechnology genetics journal from Cell Press. With an impact factor of 64.5, it offers unparalleled prestige for groundbreaking research in cell biology and molecular mechanisms. Ideal for submitting high-impact papers that shape the field.
Cell stands as a cornerstone in biotechnology genetics, captivating researchers worldwide with its commitment to transformative discoveries. Launched in 1974 by Cell Press, an imprint of Elsevier, this journal has evolved into a beacon for cutting-edge science. Its pages chronicle breakthroughs in cellular processes, genetic regulation, and molecular interactions that redefine biological understanding. The journal's rigorous peer-review process ensures only the most innovative work sees publication, fostering a legacy of excellence that spans decades.
Researchers gravitate toward Cell for its ability to amplify their voices in a crowded academic landscape. With a focus on interdisciplinary approaches, it bridges biochemistry, genetics, and beyond, inviting submissions that push boundaries. The impact factor of 64.5, as reported by Clarivate Journal Citation Reports for 2022, underscores its influence, placing it among the elite in life sciences. This metric reflects not just citation counts but the journal's role in driving global research agendas.
Publishing in Cell opens doors to collaborations, funding opportunities, and career advancement. Its readership, comprising leading scientists and institutions, ensures wide dissemination of findings. For those navigating the submission process, Cell provides clear guidelines via its online portal, emphasizing originality and broad appeal. Whether exploring gene editing or cellular signaling, contributors find a platform that values depth and novelty.
The journal's hybrid model balances subscription access with open options, making research accessible while supporting sustainability. Editorial oversight from renowned experts maintains high standards, with decisions informed by scientific merit alone. As biotechnology genetics advances rapidly, Cell remains at the forefront, chronicling pivotal moments like CRISPR developments and epigenetic insights.
To elevate your research profile, consider submitting to Cell today. Explore biology jobs or connect with peers via Rate My Professor for insights into academic networks.
Cell was founded in 1974 by Benjamin Lewin under MIT Press, later acquired by Cell Press in 1986. It quickly gained prominence for publishing seminal papers on DNA replication and oncogenes. Today, headquartered in the United States, it publishes biweekly, serving as a vital resource for biotechnology genetics advancements. Its evolution mirrors the field's growth, from basic molecular biology to applied genomics.
Cell encompasses a broad spectrum within biotechnology genetics, emphasizing mechanisms underlying cellular function and genetic control. Key areas include cell signaling, gene expression, developmental biology, and structural biology.
| Discipline | Description |
|---|---|
| Biochemistry | Studies molecular interactions in cellular processes. |
| Molecular Biology | Focuses on gene regulation and protein synthesis. |
| Genetics | Explores inheritance patterns and genomic variations. |
| Cell Biology | Investigates organelle dynamics and cytoskeletal functions. |
| Biotechnology | Applies genetic tools for therapeutic and industrial innovations. |
| Metric | Value | Source |
|---|---|---|
| Impact Factor (2022) | 64.5 | Clarivate JCR |
| 5-Year Impact Factor | 58.7 | Clarivate JCR |
| CiteScore | 68.2 | Scopus |
| h-Index | 1000+ | Scopus |
| Acceptance Rate | Not publicly disclosed | N/A |
Cell is indexed in major databases, ensuring visibility. It appears in PubMed/MEDLINE, Scopus, Web of Science, and Embase. These services facilitate discoverability, with abstracts available through the official journal homepage. DOAJ listing is not applicable as it's not fully open access.
Cell operates a hybrid model, offering subscription-based access with optional open access via Elsevier's agreements. Article Processing Charges (APCs) for gold open access are approximately $11,000, though waivers apply for certain regions. Sherpa/RoMEO classifies it as green archiving compliant, allowing preprint deposits.
Submissions are handled through Editorial Manager at Cell's submission portal. Authors must prepare manuscripts per detailed guidelines, including cover letters highlighting novelty. Pre-submission inquiries are encouraged for complex studies. Review typically spans 4-6 weeks, with revisions possible.
The board features luminaries like Editor-in-Chief Barbara Meyer, a pioneer in RNA processing. Members hail from Harvard, Stanford, and international institutions, bringing expertise in genetics and biotechnology. Their diverse backgrounds ensure balanced evaluation.
Publishing in Cell elevates visibility and credibility. Its high impact factor attracts citations, boosting h-indexes. The journal's prestige aids tenure and grants. Moreover, it connects authors to a global network, fostering collaborations in biotechnology genetics.
| Journal | Impact Factor | Publisher | Focus |
|---|---|---|---|
| Nature | 64.8 | Springer Nature | Broad multidisciplinary |
| Science | 56.9 | AAAS | General science |
| Nature Genetics | 41.3 | Springer Nature | Human genetics |
| Molecular Cell | 16.6 | Cell Press | Cellular mechanisms |
| Genes & Development | 8.5 | Cold Spring Harbor | Developmental genetics |
Integrate links to resources like genetics jobs, biotech jobs, higher ed jobs, academic calendar, and Rate My Professor for career support.